Cd4+ T cell subsets during virus infection: Protective capacity depends on effector cytokine secretion and on migratory capability

Journal of Experimental Medicine

Volumn 191, Issue 12, 2000, Pages 2159-2170

  Maloy, Kevin J ^a,d   Burkhart, Christoph ^a,c   Junt, Tobias M ^a   Odermatt, Bernhard ^a   Oxenius, Annette ^a   Piali, Luca ^b   Zinkernagel, Rolf M ^a   Hengartner, Hans ^a  

^a INSTITUTE OF EXPERIMENTAL IMMUNOLOGY   (Switzerland)

^b UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

^c Inselsspital ^*  (Switzerland)

^d UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Chemokines; Migration; Th1 Th2 cells; Vaccinia; Vesicular stomatitis virus

Indexed keywords

CHEMOKINE; CYTOKINE; VIRUS GLYCOPROTEIN;

ANIMAL CELL; ANTIBODY PRODUCTION; ANTIVIRAL ACTIVITY; ARTICLE; CYTOKINE RELEASE; DELAYED HYPERSENSITIVITY; LYMPHOCYTE MIGRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; TRANSGENIC MOUSE; VESICULAR STOMATITIS VIRUS; VIRUS INFECTION;

ADOPTIVE TRANSFER; ANIMALS; ANTIBODIES, VIRAL; CD4-POSITIVE T-LYMPHOCYTES; CHEMOTAXIS, LEUKOCYTE; CYTOKINES; HYPERSENSITIVITY, DELAYED; IMMUNOGLOBULIN G; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; NEUTRALIZATION TESTS; RHABDOVIRIDAE INFECTIONS; T-LYMPHOCYTE SUBSETS; TH1 CELLS; TH2 CELLS; VESICULAR STOMATITIS-INDIANA VIRUS; VIRAL ENVELOPE PROTEINS;

EID: 0034686536     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.191.12.2159     Document Type: Article

References (72)

1. Zinkernagel, R.M. 1996. Immunology taught by viruses. Science. 271:173-178.
2. Ramshaw, I.A., A.J. Ramsay, G. Karupiah, M.S. Rolph, S. Mahalingam, and J.C. Ruby. 1997. Cytokines and immunity to viral infections. Immunol. Rev. 159:119-135.
3. Czarniecki, C.W., C.W. Fennie, D.B. Powers, and D.A. Estell. 1984. Synergistic antiviral and antiproliferative activities of Escherichia coli-derived human alpha, beta and gamma interferons. J. Virol. 49:490-496.
4. Wong, G.H.W., and D. Goeddel. 1986. Tumour necrosis factors α and β inhibit virus replication and synergize with interferons. Nature. 323:819-822.
5. Leist, T.P., S.P. Cobbold, H. Waldmann, M. Aguet, and R.M. Zinkernagel. 1987. Functional analysis of T lymphocyte subsets in antiviral host defense. J. Immunol. 138:2278-2281.
6. Kasaian, M.T., M.K. Leite, and C.A. Biron. 1991. The role of CD4+ cells in sustaining lymphocyte proliferation during lymphocytic choriomeningitis virus infection. J. Immunol. 146:1955-1963.
7. Leist, T.P., M. Kohler, and R.M. Zinkernagel. 1989. Impaired generation of antiviral cytotoxicity against lymphocytic choriomeningitis and vaccinia virus in mice treated with CD4-specific monoclonal antibody. Scand. J. Immunol. 30: 679-686.
8. Matloubian, M., R.J. Conception, and R. Ahmed. 1994. CD4+ T cells are required to sustain CD8+ cytotoxic T cell responses during chronic viral infection. J. Virol. 68:8056-8063.
9. + T cells. J. Exp. Med. 174:875-880.
10. Scherle, P.A., G. Palladino, and W. Gerhard. 1992. Mice can recover from pulmonary influenza virus infection in the absence of class I-restricted cytotoxic T cells. J. Immunol. 148: 212-217.
11. + T helper type 2 T lymphocytes do not promote recovery from experimental virus infection. J. Exp. Med. 180:1273-1282.
12. Spriggs, M.K., B.H. Koller, T. Sato, P.J. Morrissey, W.C. Fanslow, O. Smithies, R.F. Voice, M.B. Widmer, and C.R. Maliszewski. 1992. β2-microglobulin-, CD8+ T-cell-deficient mice survive inoculation with high doses of vaccinia virus and exhibit altered IgG responses. Proc. Natl. Acad. Sci. USA. 89:6070-6074.
13. Kägi, D., P. Seiler, J. Pavlovic, B. Ledermann, K. Bürki, R.M. Zinkernagel, and H. Hengartner. 1995. The roles of perforin and Fas-dependent cytotoxicity in protection against cytopathic and non-cytopathic viruses. Eur. J. Immunol. 25: 3256-3262.
14. + T cell clones with both cytotoxic and helper activity mediate protective humoral immunity against a lethal poliovirus infection in transgenic mice expressing the human poliovirus receptor. J. Exp. Med. 181:1285-1292.
15. Mosmann, T.R., and R.L. Coffman. 1989. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 7:145-173.
16. Abbas, A.K., K.M. Murphy, and A. Sher. 1996. Functional diversity of helper T lymphocytes. Nature. 383:787-793.
17. O'Garra, A. 1998. Cytokines induce the development of functionally heterogeneous T helper subsets. Immunity. 8:275-283.
18. Reiner, S.L., Z.E. Wang, F. Hatam, P. Scott, and R.M. Locksley. 1993. Th1 and Th2 cell antigen receptors in experimental leishmaniasis. Science. 259:1457-1460.
19. Else, K.J., F.D. Finkelman, C.R. Maliszewski, and R.K. Grencis. 1994. Cytokine-mediated regulation of chronic intestinal helminth infection. J. Exp. Med. 179:347-351.
20. Urban, J.F., Jr., N. Noben-Trauth, D.D. Donaldson, K.B. Madden, S.C. Morris, M. Collins, and F.D. Finkelman. 1998. IL-13, IL-4Rα and Stat6 are required for the expulsion of the gastrointestinal nematode parasite Nippostrongylus brasiliensis. Immunity. 8:255-264.
21. Lefrancois, L. 1984. Protection against lethal viral infection by neutralizing and nonneutralizing monoclonal antibodies: distinct mechanisms of action in vivo. J. Virol. 51:208-214.
22. Thomsen, A.R., A. Nansen, C. Anderson, J. Johansen, O. Marker, and J.P. Christensen. 1997. Cooperation of B and T cells is required for survival of mice infected with vesicular stomatitis virus. Int. Immunol. 9:1757-1766.
23. Maloy, K.J., C. Burkhart, G. Freer, T. Rülicke, H.P. Pircher, D.H. Kono, A.N. Theofilopoulos, B. Ludewig, U. Hoffman-Rohrer, R.M. Zinkernagel, and H. Hengartner. 1999. Qualitative and quantitative requirements for CD4+ T cell-mediated antiviral protection. J. Immunol. 162:2867-2874.
24. Oxenius, A., M.F. Bachmann, R.M. Zinkernagel, and H. Hengartner. 1998. Virus-specific MHC class II-restricted TCR-transgenic mice: effects on humoral and cellular immune responses after viral infection. Eur. J. Immunol. 28:390-400.
25. Mombaerts, P., E. Mizoguchi, H.G. Ljunggren, J. Iacomini, H. Ishikawa, L. Wang, M.J. Grusby, L.H. Glimcher, H.J. Winn, A.K. Bhan, and S. Tonegawa. 1994. Peripheral lymphoid development and function in TCR mutant mice. Int. Immunol. 6:1061-1070.
26. Assenmacher, M., J. Schmitz, and A. Radbruch. 1994. Flow cytometric determination of cytokines in activated murine T helper lymphocytes: expression of interleukin-10 in interferon-gamma and in interleukin-4-expressing cells. Eur. J. Immunol. 24:1097-1101.
27. Charan, S., and R.M. Zinkernagel. 1986. Antibody mediated suppression of secondary IgM response in nude mice against vesicular stomatitis virus. J. Immunol. 136:3057-3061.
28. Bachmann, M.F., T.M. Kündig, C. Kalberer, H. Hengartner, and R.M. Zinkernagel. 1993. Formalin inactivation of vesicular stomatitis virus impairs T-cell-but not T-help-independent B cell responses. J. Virol. 67:3917-3922.
29. Mackett, M., T. Yilma, J.K. Rose, and B. Moss. 1985. Vaccinia virus recombinants: expression of VSV genes and protective immunization of mice and cattle. Science. 227:433-435.
30. Schulz, M., P. Aichele, M. Vollenweider, F.W. Bobe, F. Cardinaux, H. Hengartner, and R.M. Zinkernagel. 1989. MHC dependent T cell epitopes of LCMV nucleoprotein and their protective capacity against viral disease. Eur. J. Immunol. 19:1657-1667.
31. Kimmig, W., and G.F. Lehmann. 1979. The immune response of the mouse to lymphocytic choriomeningitis virus. I. Circulating antibodies. J. Gen. Virol. 45:703-710.
32. Burkhart, C., G. Freer, R.U. Steinhoff, Y. Li, D.H. Bishop, R.M. Zinkernagel, and H. Hengartner. 1994. Localization of T helper cell epitopes in the vesicular stomatitis virus: the nucleoprotein is responsible for serotype cross-reactive help. Viral Immunol. 7:103-111.
33. Wagner, R.R., R.M. Snyder, and S. Yamazaki. 1970. Proteins of vesicular stomatitis virus: kinetics and cellular sites of synthesis. J. Virol. 5:548-558.
34. Scott, D.W., and R.K. Gershon. 1970. Determination of total and mercaptoethanol-resistant antibody in the same serum sample. Clin. Exp. Immunol. 6:313-317.
35. Binder, D., and T.M. Kündig. 1991. Antiviral protection by CD8+ versus CD4+ T cells: CD8+ T cells correlating with cytotoxic activity in vitro are more efficient in antivaccinia virus protection than CD4-dependent interleukins. J. Immunol. 146:4301-4307.
36. Burkhart, C., G. Freer, R. Castro, L. Adorini, K.H. Wiesmüller, R.M. Zinkernagel, and H. Hengartner. 1994. Characterization of T helper epitopes of the glycoprotein of vesicular stomatitis virus. J. Virol. 68:1573-1580.
37. Openshaw, P., E.E. Murphy, N.A. Hosken, V. Maino, K. Davis, K. Murphy, and A. O'Garra. 1995. Heterogeneity of intracellular cytokine synthesis at the single-cell level in polarized T helper 1 and T helper 2 populations. J. Exp. Med. 182:1357-1367.
38. Leist, T.P., M. Eppler, and R.M. Zinkernagel. 1989. Enhanced virus replication and inhibition of lymphocytic choriomeningitis virus disease in anti-IFN gamma-treated mice. J. Virol. 63:2813-2819.
39. Murphy, E., K. Shibuya, N. Hosken, P. Openshaw, V. Maino, K. Davis, K. Murphy, and A. O'Garra. 1996. Reversibility of T helper 1 and 2 populations is lost after long-term stimulation. J. Exp. Med. 183:901-913.
40. Bachmann, M.F., B. Odermatt, H. Hengartner, and R.M. Zinkernagel. 1996. Induction of long-lived germinal centers associated with persisting antigen after viral infection. J. Exp. Med. 183:2259-2269.
41. Maloy, K.J., B. Odermatt, H. Hengartner, and R.M. Zinkernagel. 1998. Interferon γ-producing γδ T cell-dependent antibody isotype switching in the absence of germinal center formation during virus infection. Proc. Natl. Acad. Sci. USA. 95:1160-1165.
42. Kündig, T., I. Castelmur, M.F. Bachmann, D. Abraham, D. Binder, H. Hengartner, and R.M. Zinkernagel. 1993. Fewer protective cytotoxic T cell epitopes than T helper cell epitopes on vesicular stomatitis virus. J. Virol. 67:3680-3683.
43. Cudmore, S., P. Cossart, G. Griffiths, and M. Way. 1995. Actin-based motility of vaccinia virus. Nature. 378:636-638.
44. Smith, G.L. 1999. Vaccinia virus immune evasion. Immunol. Lett. 65:55-62.
45. Springer, T.A. 1994. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell. 76:301-314.
46. Butcher, E.C., and L.J. Picker. 1996. Lymphocyte homing and homeostasis. Science. 272:60-66.
47. O'Garra, A., L.M. McEvoy, and A. Zlotnik. 1998. T-cell subsets: chemokine receptors guide the way. Curr. Biol. 8:R646-R649.
48. Sallusto, F., A. Lanzavecchia, and C.R. Mackay. 1998. Chemokines and chemokine receptors in T-cell priming and Th1/Th2-mediated responses. Immunol. Today. 19:568-574.
49. Sivike, J.T., and A. Hamann. 1998. T helper 1 and T helper 2 cells respond differentially to chemokines. J. Immunol. 160: 550-554.
50. Plakhov, I.V., C. Aoki, E.G. Arlund, and C.S. Reiss. 1995. The earliest events in VSV infection of the murine olfactory epithelium and entry of the central nervous system. Virology. 209:257-262.
51. Christian, A.Y., M. Barna, Z. Bi, and C.S. Reiss. 1996. Host immune response to vesicular stomatitis virus infection of the central nervous system in C57BL/6 mice. Viral Immunol. 9:195-205.
52. Bachmann, M.F., U. Kalinke, A. Althage, G. Freer, C. Burkhart, H. Roost, M. Aguet, H. Hengartner, and R.M. Zinkernagel. 1997. The role of antibody concentration and avidity in antiviral protection. Science. 276:2024-2027.
53. Coutelier, J.P., J.T.M. Van der Logt, F.W.A. Heessen, G. Warnier, and J.V. Van Snick. 1987. IgG2a restriction of murine antibodies elicited by viral infections. J. Exp. Med. 165: 64-69.
54. Finkelman, F.D., J. Holmes, I.M. Katona, J. Urban, M.P. Beckmann, L.S. Park, K.A. Scholley, R.L. Coffman, T.R. Mosmann, and W.E. Paul. 1990. Lymphokine control of in vivo immunoglobulin isotype secretion. Annu. Rev. Immunol. 8:303-333.
55. Lee, W.T., and E.S. Vitetta. 1991. The differential expression of homing and adhesion molecules on virgin and memory T cells in the mouse. Cell. Immunol. 132:215-222.
56. Mackay, C.R. 1993. Homing of naive, memory and effector lymphocytes. Curr. Opin. Immunol. 5:423-427.
57. Austrup, F., D. Westweber, E. Borges, M. Löhning, R. Bräuer, U. Herz, H. Renz, R. Hallman, A. Scheffold, A. Radbruch, and A. Hamann. 1997. P- and E-selectin mediate recruitment of T helper 1 but not T helper 2 cells into inflamed tissues. Nature. 385:81-84.
58. Asensio, V.C., and I.L. Campbell. 1997. Chemokine gene expression in the brains of mice with lymphocytic choriomeningitis. J. Virol. 71:7832-7840.
59. Kündig, T.M., M.F. Bachmann, S. Oehen, U.W. Hoffmann, J.J.L. Simard, C.P. Kalberer, H. Pircher, P.S. Ohashi, H. Hengartner, and R.M. Zinkernagel. 1996. On the role of antigen in maintaining cytotoxic T-cell memory. Proc. Natl. Acad. Sci. USA. 93:9716-9723.
60. Bachmann, M.F., T.M. Kündig, H. Hengartner, and R.M. Zinkernagel. 1997. Protection against immunopathological consequences of a viral infection by activated but not resting cytotoxic T cells: T cell memory without "memory T cells"? Proc. Natl. Acad. Sci. USA. 94:640-645.
61. Cerwenka, A., T.M. Morgan, A.G. Harmsen, and R.W. Dutton. 1999. Migration kinetics and final destination of type 1 and type 2 CD8 effector cells predict protection against pulmonary virus infection. J. Exp. Med. 189:423-434.
62. Bi, Z., P. Quandt, T. Komatsu, M. Barna, and C.S. Reiss. 1995. IL-12 promotes enhanced recovery from vesicular stomatitis virus infection of the central nervous system. J. Immunol. 155:5684-5689.
63. Kündig, T.M., H. Hengartner, and R.M. Zinkernagel. 1993. T cell dependent interferon gamma exerts an antiviral effect in the central nervous system but not in peripheral solid organs. J. Immunol. 150:2316-2323.
64. Jonjic, S., I. Pavic, P. Lucin, D. Rukavina, and U.H. Koszinowski. 1990. Efficacious control of cytomegalovirus infection after long-term depletion of CD8+ T lymphocytes. J. Virol. 64:5457-5464.
65. Manickan, E., M. Francotte, N. Kuklin, M. Dewerchin, C. Molitor, D. Gheysen, M. Slaoui, and B.T. Rouse. 1995. Vaccination with recombinant vaccinia virus expressing ICP27 induces protective immunity against herpes simplex virus through CD4+ Th1 T cells. J. Virol. 69:4711-4716.
66. Reich, A., O. Erlwein, S. Niewiesk, V. Ter Meulen, and U.G. Liebert. 1992. CD4+ T cells control measles virus infection in the central nervous system. Immunology. 76:185-191.
67. Orange, J.S., S.F. Wolf, and C.A. Biron. 1994. Effects of IL-12 on the response and susceptibility to experimental viral infections. J. Immunol. 152:1253-1264.
68. Carr, J.A., J. Rogerson, M.J. Mulqueen, N.A. Roberts, and R.F.G. Booth. 1997. Interleukin-12 exhibits potent antiviral activity in experimental herpesvirus infections. J. Virol. 71: 7799-7803.
69. Coutelier, J.P., J. Van Broeck, and S.F. Wolf. 1995. Interleukin-12 gene expression after viral infection in the mouse. J. Virol. 69:1955-1958.
70. Oxenius, A., U. Karrer, R.M. Zinkernagel, and H. Hengartner. 1999. IL-12 is not required for induction of type 1 cytokine responses in viral infections. J. Immunol. 162:965-973.
71. Kägi, D., B. Ledermann, K. Bürki, P. Seiler, H. Odermatt, K.J. Olsen, E. Podack, R.M. Zinkernagel, and H. Hengartner. 1994. Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice. Nature. 369:31-37.
72. Oxenius, A., R.M. Zinkernagel, and H. Hengartner. 1998. Comparison of activation versus induction of unresponsiveness of virus-specific CD4+ and CD8+ T cells upon acute versus persistent viral infection. Immunity. 9:449-457.